Aurobindo Pharma Ltd. (AUROPHARMA)
NSE
Closed
Sep 9, 2026
Day's Range
1,672.0052 wk Range
1,036.00Profile - AUROPHARMA - Aurobindo Pharma Ltd.
Profile
Mic Code
XNSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
29.20K
Aurobindo Pharma Ltd. is a prominent pharmaceutical company engaged in the manufacturing and marketing of a broad range of generic pharmaceuticals and active pharmaceutical ingredients (APIs). The primary function of Aurobindo Pharma is to supply affordable healthcare products and solutions across a variety of therapeutic categories, including antibiotics, antiretrovirals, cardiovascular products, gastroenterologicals, and central nervous system agents. Known for its comprehensive portfolio, Aurobindo serves multiple sectors by addressing the healthcare needs of both developed and emerging markets. The company plays a significant role in the global pharmaceutical industry by maintaining numerous manufacturing facilities that meet international standards, securing regulatory approvals in major markets such as the United States, Europe, and Japan. Aurobindo's R&D capabilities are notable, with a strong commitment to innovation and excellence in drug development and delivery. Established in 1986 and based in Hyderabad, India, Aurobindo Pharma Ltd. is pivotal in enhancing access to essential medicines worldwide, reflecting its market significance linked to its expansive supply chain and diverse product offerings.
Profile Details
Type
Common Stock
Address
Galaxy, Plot No. 1
City
Hyderabad
Zip
500032
Country
India
Phone
91 40 6672 5000
Key Executives - AUROPHARMA - Aurobindo Pharma Ltd.
Key executives
Cross Listings - AUROPHARMA - Aurobindo Pharma Ltd.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
